LUCIER PHARMACEUTICALS INC filed a Form D with the Securities and Exchange Commission on 2026-10-13.
LUCIER PHARMACEUTICALS INC filed a Form D notice of an exempt securities offering with the SEC on October 13, 2026. Its industry group is Pharmaceuticals. It names Guangrong Lu Lu (CEO and the issuer is the same person. Lcuier was originally registered at his home address. New business address is in Bryan, TX recently.) (SEC Form D, October 13, 2026).
Sell to companies like LUCIER PHARMACEUTICALS INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns LUCIER PHARMACEUTICALS INC.
Free to see. No signup.
More on the people and the money behind LUCIER PHARMACEUTICALS INC, from the filings we hold.
Pharmaceuticals raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when LUCIER PHARMACEUTICALS INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when LUCIER PHARMACEUTICALS INC raises, hires or launches. No email unless you switch it on.
Watch LUCIER PHARMACEUTICALS INC →Get the full cited report on LUCIER PHARMACEUTICALS INC
What the filing shows about LUCIER PHARMACEUTICALS INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on LUCIER PHARMACEUTICALS INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on LUCIER PHARMACEUTICALS INC See pricing
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Lucier Pharma develops drug candidates targeting the unique mechanisms of coronary microvessels to treat endotype-specific coronary microvascular dysfunction (CMD).
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer.
Guangrong Lu Lu is named as Ceo and the issuer is the same person. Lcuier was originally registered at his home address. New business address is in Bryan, Tx recently. on the Form D that LUCIER PHARMACEUTICALS INC filed with the SEC on 13 October 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-10-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about LUCIER PHARMACEUTICALS INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on LUCIER PHARMACEUTICALS INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LUCIER PHARMACEUTICALS INC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist LUCIER PHARMACEUTICALS INCYou get an alert in MentionFox the next time this company shows up.
If you're behind LUCIER PHARMACEUTICALS INC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-16 (lucierpharma.com).
Each opens in a new tab, filled in for LUCIER PHARMACEUTICALS INC. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises, week of 2026-10-12 · The rest of the US raises, week of 2026-10-12
https://mentionfox.com/funding/lucier-pharmaceuticals-inc-form-d-000003